Literature DB >> 21894294

Thoracic wall ultrasonography - normal and pathological findings. Pictorial essay.

Romeo Chira1, Alexandra Chira, Petru Adrian Mircea.   

Abstract

Ultrasonography represents an efficient diagnosis method for thoracic pathology evaluation. The diseases of the pleura and thoracic wall receive the greatest benefit from the ultrasound examination. Establishing the cause of an acute thoracic pain or assessing a palpable tumor may easily benefit from essential data provided by ultrasonography. Afterwards it is possible to use a complementary imaging method or to perform US guided interventional procedures. This pictorial presents the ultrasonographic aspects of thoracic wall pathology, considering also differential diagnosis issues.

Entities:  

Mesh:

Year:  2011        PMID: 21894294

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  5 in total

1.  MDCT and US of intrathoracic extrapleural space soft tissue-containing lesions: US extrapleural fat sign and MDCT fat ghost ribs sign.

Authors:  Tullio Valente; Giovanni Tortora; Giorgio Bocchini; Gaetano Rea; Maurizio Marino; Maurizio Muto
Journal:  Radiol Med       Date:  2017-03-03       Impact factor: 3.469

2.  Primary lung tumour invading the chest wall.

Authors:  Mark Charnock
Journal:  Ultrasound       Date:  2021-01-10

Review 3.  Chest wall - a structure underestimated in ultrasonography. Part III: Neoplastic lesions.

Authors:  Andrzej Smereczyński; Katarzyna Kołaczyk; Elżbieta Bernatowicz
Journal:  J Ultrason       Date:  2017-12-29

Review 4.  Chest wall - underappreciated structure in sonography. Part II: Non-cancerous lesions.

Authors:  Andrzej Smereczyński; Katarzyna Kołaczyk; Elżbieta Bernatowicz
Journal:  J Ultrason       Date:  2017-12-29

Review 5.  Ten Years of Pediatric Lung Ultrasound: A Narrative Review.

Authors:  Anna Maria Musolino; Paolo Tomà; Cristina De Rose; Eugenio Pitaro; Elena Boccuzzi; Rita De Santis; Rosa Morello; Maria Chiara Supino; Alberto Villani; Piero Valentini; Danilo Buonsenso
Journal:  Front Physiol       Date:  2022-01-06       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.